Latest News in the pharma Industry

Policy & Regulation

FDA approves first  and only medicine in a new class of acute treatment for migraine

FDA approves first and only medicine in a new class of acute treatment for migraine

15 Oct 2019

The approval of Eli Lilly's Reyvow represents the first new class of acute migraine treatment approved by the FDA in more than two decades.

Read more 
Unidose device approved for Tosymra sumatriptan spray

Unidose device approved for Tosymra sumatriptan spray

3 Oct 2019

Provides migraine sufferers with a convenient, patient-friendly delivery approach.

Read more 
EC approves its first plant-derived cannabis-based medicine

EC approves its first plant-derived cannabis-based medicine

24 Sep 2019

Epidyolex (cannabidiol) approved for the treatment of seizures in patients with two rare, severe forms of childhood-onset epilepsy.

Read more 
Taiwan's biggest CDMO secures FDA approval

Taiwan's biggest CDMO secures FDA approval

3 Sep 2019

Customers claim Bora's oral solid dosage Zhunan facility is in the top 5 external manufacturing facilities they’ve ever visited in the world.

Read more 
FDA warns OTC drug manufacturer for drug manufacturing data integrity violations

FDA warns OTC drug manufacturer for drug manufacturing data integrity violations

21 Aug 2019

Company provided FDA investigators with multiple documents that were falsified.

Read more 
FDA approves Aptar's needle-free rescue treatment for severe hypoglycemia

FDA approves Aptar's needle-free rescue treatment for severe hypoglycemia

25 Jul 2019

Aptar’s nasal Unidose device - the result of a 10-year customer collaboration - marks the first FDA approval of a prescription drug using the company’s patented Unidose Powder System.

Read more 
Legacy ramps up preparations for new Russian track and trace sterilisation regulations

Legacy ramps up preparations for new Russian track and trace sterilisation regulations

18 Jul 2019

Company to install new inspection cameras with higher resolution to ensure readability of more complex codes demanded by the Russian mandated crypto coding.

Read more 
Particle Sciences expands controlled substance capabilities

Particle Sciences expands controlled substance capabilities

27 May 2019

Now authorized to test, develop and manufacture cannabis-derived pharmaceutical materials.

Read more 
Brexit's trick or treat on patient safety

Brexit's trick or treat on patient safety

29 Apr 2019

Despite a delayed Brexit, unpredictability adds further complications to the EU FMD regulation.

Read more 
WuXi STA’s new drug product manufacturing facility passes first European MPA GMP Inspection

WuXi STA’s new drug product manufacturing facility passes first European MPA GMP Inspection

27 Mar 2019

CDMO positioned to empower more customers to develop innovative drugs faster and more efficiently.

Read more 
TraceLink submits an interoperable blockchain network solution for FDA DSCSA Pilot Project Program

TraceLink submits an interoperable blockchain network solution for FDA DSCSA Pilot Project Program

12 Mar 2019

Trace Histories is a purpose-built distributed ledger solution for ensuring patient safety by 2023 DSCSA deadline.

Read more 
Recipharm achieves new ISO 45001 certification to support sustainability efforts

Recipharm achieves new ISO 45001 certification to support sustainability efforts

28 Feb 2019

ISO 45001 developed to improve employee safety, reduce workplace risk and create better working conditions globally.

Read more